308 related articles for article (PubMed ID: 28040716)
1. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017.
Daly MB; Pilarski R; Berry M; Buys SS; Farmer M; Friedman S; Garber JE; Kauff ND; Khan S; Klein C; Kohlmann W; Kurian A; Litton JK; Madlensky L; Merajver SD; Offit K; Pal T; Reiser G; Shannon KM; Swisher E; Vinayak S; Voian NC; Weitzel JN; Wick MJ; Wiesner GL; Dwyer M; Darlow S
J Natl Compr Canc Netw; 2017 Jan; 15(1):9-20. PubMed ID: 28040716
[TBL] [Abstract][Full Text] [Related]
2. EMQN best practice guidelines for genetic testing in hereditary breast and ovarian cancer.
McDevitt T; Durkie M; Arnold N; Burghel GJ; Butler S; Claes KBM; Logan P; Robinson R; Sheils K; Wolstenholme N; Hanson H; Turnbull C; Hume S
Eur J Hum Genet; 2024 May; 32(5):479-488. PubMed ID: 38443545
[TBL] [Abstract][Full Text] [Related]
3. Promoting guideline-based cancer genetic risk assessment for hereditary breast and ovarian cancer in ethnically and geographically diverse cancer survivors: Rationale and design of a 3-arm randomized controlled trial.
Kinney AY; Howell R; Ruckman R; McDougall JA; Boyce TW; Vicuña B; Lee JH; Guest DD; Rycroft R; Valverde PA; Gallegos KM; Meisner A; Wiggins CL; Stroup A; Paddock LE; Walters ST
Contemp Clin Trials; 2018 Oct; 73():123-135. PubMed ID: 30236776
[TBL] [Abstract][Full Text] [Related]
4. Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?
Kahn RM; Ahsan MD; Chapman-Davis E; Holcomb K; Nitecki R; Rauh-Hain JA; Fowlkes RK; Tubito F; Pires M; Christos PJ; Tkachuk K; Krinsky H; Sharaf RN; Offit K; Lipkin S; Frey MK
Fam Cancer; 2023 Apr; 22(2):127-133. PubMed ID: 36207653
[TBL] [Abstract][Full Text] [Related]
5. Evaluation and comparison of hereditary Cancer guidelines in the population.
Ritchie JB; Bellcross C; Allen CG; Frey L; Morrison H; Schiffman JD; Welch BM
Hered Cancer Clin Pract; 2021 Jul; 19(1):31. PubMed ID: 34274008
[TBL] [Abstract][Full Text] [Related]
6. Prostate Cancer, Version 3.2024.
Schaeffer EM; Srinivas S; Adra N; An Y; Bitting R; Chapin B; Cheng HH; D'Amico AV; Desai N; Dorff T; Eastham JA; Farrington TA; Gao X; Gupta S; Guzzo T; Ippolito JE; Karnes RJ; Kuettel MR; Lang JM; Lotan T; McKay RR; Morgan T; Pow-Sang JM; Reiter R; Roach M; Robin T; Rosenfeld S; Shabsigh A; Spratt D; Szmulewitz R; Teply BA; Tward J; Valicenti R; Wong JK; Snedeker J; Freedman-Cass DA
J Natl Compr Canc Netw; 2024 Apr; 22(3):140-150. PubMed ID: 38626801
[TBL] [Abstract][Full Text] [Related]
7. Statement on guidance for genetic counseling in advanced paternal age.
Toriello HV; Meck JM;
Genet Med; 2008 Jun; 10(6):457-60. PubMed ID: 18496227
[TBL] [Abstract][Full Text] [Related]
8. Genetic testing for familial/hereditary breast cancer-comparison of guidelines and recommendations from the UK, France, the Netherlands and Germany.
Gadzicki D; Evans DG; Harris H; Julian-Reynier C; Nippert I; Schmidtke J; Tibben A; van Asperen CJ; Schlegelberger B
J Community Genet; 2011 Jun; 2(2):53-69. PubMed ID: 22109790
[TBL] [Abstract][Full Text] [Related]
9. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017.
Gupta S; Provenzale D; Regenbogen SE; Hampel H; Slavin TP; Hall MJ; Llor X; Chung DC; Ahnen DJ; Bray T; Cooper G; Early DS; Ford JM; Giardiello FM; Grady W; Halverson AL; Hamilton SR; Klapman JB; Larson DW; Lazenby AJ; Lynch PM; Markowitz AJ; Mayer RJ; Ness RM; Samadder NJ; Shike M; Sugandha S; Weiss JM; Dwyer MA; Ogba N
J Natl Compr Canc Netw; 2017 Dec; 15(12):1465-1475. PubMed ID: 29223984
[TBL] [Abstract][Full Text] [Related]
10. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020.
Daly MB; Pilarski R; Yurgelun MB; Berry MP; Buys SS; Dickson P; Domchek SM; Elkhanany A; Friedman S; Garber JE; Goggins M; Hutton ML; Khan S; Klein C; Kohlmann W; Kurian AW; Laronga C; Litton JK; Mak JS; Menendez CS; Merajver SD; Norquist BS; Offit K; Pal T; Pederson HJ; Reiser G; Shannon KM; Visvanathan K; Weitzel JN; Wick MJ; Wisinski KB; Dwyer MA; Darlow SD
J Natl Compr Canc Netw; 2020 Apr; 18(4):380-391. PubMed ID: 32259785
[TBL] [Abstract][Full Text] [Related]
11. Cost Comparison of Genetic Testing Strategies in Women With Epithelial Ovarian Cancer.
Foote JR; Lopez-Acevedo M; Buchanan AH; Secord AA; Lee PS; Fountain C; Myers ER; Cohn DE; Reed SD; Havrilesky LJ
J Oncol Pract; 2017 Feb; 13(2):e120-e129. PubMed ID: 28045615
[TBL] [Abstract][Full Text] [Related]
12. Decision making for breast cancer prevention among women at elevated risk.
Padamsee TJ; Wills CE; Yee LD; Paskett ED
Breast Cancer Res; 2017 Mar; 19(1):34. PubMed ID: 28340626
[TBL] [Abstract][Full Text] [Related]
13. Recommendations on breast cancer screening and prevention in the context of implementing risk stratification: impending changes to current policies.
Gagnon J; Lévesque E; ; Borduas F; Chiquette J; Diorio C; Duchesne N; Dumais M; Eloy L; Foulkes W; Gervais N; Lalonde L; L'Espérance B; Meterissian S; Provencher L; Richard J; Savard C; Trop I; Wong N; Knoppers BM; Simard J
Curr Oncol; 2016 Dec; 23(6):e615-e625. PubMed ID: 28050152
[TBL] [Abstract][Full Text] [Related]
14. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Kuchenbaecker KB; Hopper JL; Barnes DR; Phillips KA; Mooij TM; Roos-Blom MJ; Jervis S; van Leeuwen FE; Milne RL; Andrieu N; Goldgar DE; Terry MB; Rookus MA; Easton DF; Antoniou AC; ; McGuffog L; Evans DG; Barrowdale D; Frost D; Adlard J; Ong KR; Izatt L; Tischkowitz M; Eeles R; Davidson R; Hodgson S; Ellis S; Nogues C; Lasset C; Stoppa-Lyonnet D; Fricker JP; Faivre L; Berthet P; Hooning MJ; van der Kolk LE; Kets CM; Adank MA; John EM; Chung WK; Andrulis IL; Southey M; Daly MB; Buys SS; Osorio A; Engel C; Kast K; Schmutzler RK; Caldes T; Jakubowska A; Simard J; Friedlander ML; McLachlan SA; Machackova E; Foretova L; Tan YY; Singer CF; Olah E; Gerdes AM; Arver B; Olsson H
JAMA; 2017 Jun; 317(23):2402-2416. PubMed ID: 28632866
[TBL] [Abstract][Full Text] [Related]
15. NCCN Guidelines Insights: Breast Cancer, Version 1.2017.
Gradishar WJ; Anderson BO; Balassanian R; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goetz MP; Goldstein LJ; Isakoff SJ; Lyons J; Marcom PK; Mayer IA; McCormick B; Moran MS; O'Regan RM; Patel SA; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Sitapati A; Smith KL; Smith ML; Soliman H; Somlo G; Telli M; Ward JH; Shead DA; Kumar R
J Natl Compr Canc Netw; 2017 Apr; 15(4):433-451. PubMed ID: 28404755
[TBL] [Abstract][Full Text] [Related]
16. Multigene Testing for Hereditary Cancer: When, Why, and How.
Offit K
J Natl Compr Canc Netw; 2017 May; 15(5S):741-743. PubMed ID: 28515260
[TBL] [Abstract][Full Text] [Related]
17. Next Generation Sequencing and Multi-Gene Panel Testing: Implications for the Oncology Nurse.
Kelly PA
Semin Oncol Nurs; 2017 May; 33(2):208-218. PubMed ID: 28390840
[TBL] [Abstract][Full Text] [Related]
18. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Daly MB; Pal T; Berry MP; Buys SS; Dickson P; Domchek SM; Elkhanany A; Friedman S; Goggins M; Hutton ML; ; Karlan BY; Khan S; Klein C; Kohlmann W; ; Kurian AW; Laronga C; Litton JK; Mak JS; ; Menendez CS; Merajver SD; Norquist BS; Offit K; Pederson HJ; Reiser G; ; Senter-Jamieson L; ; Shannon KM; Shatsky R; Visvanathan K; Weitzel JN; Wick MJ; Wisinski KB; Yurgelun MB; Darlow SD; Dwyer MA
J Natl Compr Canc Netw; 2021 Jan; 19(1):77-102. PubMed ID: 33406487
[TBL] [Abstract][Full Text] [Related]
19. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
20. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 2.2019.
Gupta S; Provenzale D; Llor X; Halverson AL; Grady W; Chung DC; Haraldsdottir S; Markowitz AJ; Slavin TP; Hampel H; ; Ness RM; Weiss JM; Ahnen DJ; Chen LM; Cooper G; Early DS; Giardiello FM; Hall MJ; Hamilton SR; Kanth P; Klapman JB; Lazenby AJ; Lynch PM; Mayer RJ; Mikkelson J; ; Peter S; Regenbogen SE; Dwyer MA; ; Ogba N
J Natl Compr Canc Netw; 2019 Sep; 17(9):1032-1041. PubMed ID: 31487681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
